On Aug. 18 at a Tongji Hospital–Tianqin Bio signing event in Wuhan, six
brain–machine interface (BCI) R&D platforms were inaugurated, including
provincial BCI innovation and proof‑of‑concept centers, Tongji Hospital’s BCI
institute and joint translational lab with Tianqin Bio, and two laboratories
animal centers. A package of projects was launched, led by a National Data
Bureau BCI high‑quality dataset project with total funding of 122 mln yuan and a
24‑month build window to create multimodal datasets across 10 disease categories
(stroke rehabilitation, spinal‑cord injury, Parkinson’s, epilepsy, etc.). Hubei
health authorities also greenlighted translational projects for closed‑loop
neural modulation BCI key technologies and a Optics Valley BCI data and compute
platform.
